AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇸🇳
NAPROXENE in Senegal
9 products registered with ARP — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| APRANAX comprimé / 550 mg | 3155 | ROCHE | active | — |
| APRANAX suppositoire / 500 mg | 4017 | ROCHE | active | — |
| PRODEXIN comprimé / 500 mg | 2658 | PRODESFARMA | active | — |
| MAXIPRIN T.A comprimé / 500mg | 2990 | SANOFI WINTHROP | active | — |
| NAPROSYNE comprimé / 1000 mg | 2818 | ROUSSEL UCLAF | active | — |
| ALGIXENE suppositoire / 500 mg | 4900 | IBERSEN | active | — |
| APRANAX comprimé / 550 mg | 2731 | ROCHE | active | — |
| ALGIXENE gélule / 250 mg | 4894 | IBERSEN | active | — |
| ARTIC comprimé / 550 mg | 7048 | AMARANT | active | — |
NAPROXENE — ARP Registration Details
ARP (Senegal) has 9 registered products containing NAPROXENE, of which 9 are currently active. Data is sourced directly from the official ARP drug register and refreshed daily.
Track NAPROXENE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.